This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rudolph, B.
Right arrow Articles by Harder, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rudolph, B.
Right arrow Articles by Harder, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2006, p. 3194-3196, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.00246-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Identification of RNase 8 as a Novel Human Antimicrobial Protein

Bente Rudolph,1 Rainer Podschun,2 Hany Sahly,2 Sabine Schubert,2 Jens M. Schröder,1 and Jürgen Harder1*

Department of Dermatology,1 Institute for Infection Medicine, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany2

Received 27 February 2006/ Returned for modification 22 March 2006/ Accepted 7 July 2006

The antimicrobial activity of the human RNase A superfamily member RNase 8 was evaluated. Recombinant RNase 8 exhibited broad-spectrum microbicidal activity against potential pathogenic microorganisms (including multidrug-resistant strains) at micro- to nanomolar concentrations. Thus, RNase 8 was identified as a novel antimicrobial protein and may contribute to host defense.


* Corresponding author. Mailing address: Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Schittenhelmstr. 7, 24105 Kiel, Germany. Phone: 49 431 5971598. Fax: 49 431 5975243. E-mail: jharder{at}dermatology.uni-kiel.de.


Antimicrobial Agents and Chemotherapy, September 2006, p. 3194-3196, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.00246-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Hinrichsen, K., Podschun, R., Schubert, S., Schroder, J. M., Harder, J., Proksch, E. (2008). Mouse Beta-Defensin-14, an Antimicrobial Ortholog of Human Beta-Defensin-3. Antimicrob. Agents Chemother. 52: 1876-1879 [Abstract] [Full Text]  
  • Rosenberg, H. F. (2008). RNase A ribonucleases and host defense: an evolving story. J. Leukoc. Biol. 83: 1079-1087 [Abstract] [Full Text]  
  • Harder, J., Glaser, R., Schroder, J.-M. (2007). Review: Human antimicrobial proteins effectors of innate immunity. Innate Immunity 13: 317-338 [Abstract]  
  • Cho, S., Zhang, J. (2007). Zebrafish Ribonucleases Are Bactericidal: Implications for the Origin of the Vertebrate RNase A Superfamily. Mol Biol Evol 24: 1259-1268 [Abstract] [Full Text]  
  • Zhang, J. (2007). Disulfide-Bond Reshuffling in the Evolution of an Ape Placental Ribonuclease. Mol Biol Evol 24: 505-512 [Abstract] [Full Text]